ArticleThe oncologist2017

Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common

Julia A Elvin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.